ClinicalTrials.govpublic full text
Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)
acute exacerbation of remitting relapsing multiple sclerosis, clinically isolated syndrome, peg-liposomal prednisolone sodium phosphate, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968452
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.